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767Relation of Dimensionless Index
to Long-Term Outcome in
Aortic Stenosis With Preserved LVEFABSTRACTOBJECTIVES The aim of this study was to assess the role of the dimensionless index (DI) in a registry ofpatients with aortic stenosis (AS) to objectively establish prognostic DI thresholds for various degrees of AS severity.BACKGROUND DI is a classic marker of severity in AS that does not rely on the estimation of the left ven-tricular outﬂow tract (LVOT) cross-sectional area. Although DI estimation is straightforward, its outcome implications
have never been tested in the context of routine clinical practice.METHODS This analysis includes 488 patients with preserved ($50%) ejection fraction and no or minimalsubjective symptoms, diagnosed with $ mild AS. DI was computed as the ratio of the LVOT time-velocity integral to that
of the aortic valve jet, and on the basis of the correlation with peak aortic jet velocity, the population was divided into
3 groups: DI <0.20, DI 0.20 to 0.25, and DI >0.25.RESULTS The 5-year survival free of events (death or need for aortic valve replacement) was 56  3% for DI
>0.25, 41  6% for DI 0.20 to 0.25, and 22  5% for DI <0.20 (p for trend <0.001). The risk of events increased linearly
with DI <0.25 (adjusted hazard ratio [HR]: 1.14; 95% conﬁdence interval [CI]: 1.05 to 1.29) per 0.05 DI decrement;
p ¼ 0.015). On multivariable analysis, compared with patients with DI >0.25, those with DI 0.20 to 0.25 and those with
DI <0.20 incurred an excess risk of events (adjusted HR: 1.65; 95% CI: 1.20 to 2.27 for DI 0.20 to 0.25 vs. DI >0.25, and
adjusted HR: 2.62; 95% CI: 1.90 to 3.63 for DI <0.20 vs. DI >0.25). The association of DI and outcome was consistent in
subgroups, with no interaction between DI outcome prediction and LVOT diameter, body surface area, or index stroke
volume (all p for interaction $0.10)CONCLUSIONS Our results demonstrate that the DI is a simple and reliable marker of AS severity with clearprognostic implications. DI <0.25 is associated with an excess risk of events after diagnosis; therefore, this cutoff
should be used for AS severity assessment and for therapeutic decisions. (J Am Coll Cardiol Img 2015;8:766–75)
© 2015 by the American College of Cardiology Foundation.SEE PAGE 776S evere aortic stenosis (AS) represents a contem-porary health issue with a serious impact onhealth care providers. Elective surgery is rec-
ommended for severe symptomatic AS and for some
groups in asymptomatic individuals with severe
AS and preserved left ventricular ejection fraction
(EF) (1,2). When transvalvular ﬂow is normal, se-
vere AS is diagnosed in patients with peak aortic
jet velocity $4 m/s, mean Doppler gradient
(MDG) $40 mm Hg, aortic valve area (AVA) <1 cm2
(<0.6 cm2/m2), and dimensionless index (DI) <0.25
(1,3). Although the ﬁrst 2 parameters are highly inﬂu-
enced by the ﬂow across the aortic valve, the calcula-
tion of the size of the functional aortic oriﬁce by the
continuity equation (4) (i.e., AVA) relies on the accu-
rate measure of the left ventricular outﬂow tract
(LVOT) cross-sectional area, frequently underesti-
mated by echocardiography (5). Data showing thatthe form of the LVOT is often elliptical and not circu-
lar (6,7) and uncertainties regarding the best site for
LVOT diameter measurement (3,8,9) in patients with
severe valve calciﬁcation raise doubts over whether
AVA is the best parameter for AS quantiﬁcation.
Moreover, a recent study (10) showed that recom-
mended peak aortic jet velocity and MDG cutoffs do
not correspond to an AVA of 1 cm2. The DI represents
the ratio of the LVOT time-velocity integral to that of
the aortic valve jet (11,12), and by eliminating LVOT
cross-sectional area from the continuity equation (3)
overcomes some of these limitations.Several studies have substantiated the solid link
between increased peak aortic jet velocity and dismal
outcome in AS (13–16). MDG has rarely been validated
as a predictor of outcome in severe AS, but shows
ABBR EV I A T I ON S
AND ACRONYMS
AS = aortic stenosis
AVA = aortic valve area
CI = conﬁdence interval
DI = dimensionless index
EF = ejection fraction
HR = hazard ratio
LVOT = left ventricular
outﬂow tract
MDG = mean Doppler grad
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768a close correlation with peak aortic jet veloc-
ity, reﬂecting the same phenomenon (16,17).
In some studies, AVA <1 cm2 and indexed
AVA <0.6 cm2/m2 have been shown to affect
outcomes irrespective of peak aortic jet ve-
locity and MDG (18), whereas other reports do
not conﬁrm this association (16,19). In
contrast, the DI cutoff is based on 2 small se-
ries published in the 1980s with few support-
ive outcome data, so that the effectiveness of
this threshold as a marker and sensitive de-
tector of severe AS is untested.The present study collects consecutive patients
diagnosed with AS at the echocardiography labora-
tories of 2 French tertiary centers (Amiens and Lille)
between 2000 and 2012. We hypothesized that DI is
predictive of outcome after AS diagnosis and aimed to
deﬁne speciﬁc DI thresholds on the basis of their as-
sociation with clinical outcome.
METHODS
STUDY POPULATION. Consecutive patients$18 years
of age diagnosed with $ mild AS (aortic
valve calciﬁcation with reduction in systolic move-
ments and AVA <2 cm2) and EF $50%, managed
medically for at least 3 months after diagnosis, were
prospectively identiﬁed and included in an electronic
database. We excluded: 1) patients with $ mild aortic
and/or mitral regurgitation; 2) patients with prosthetic
valves, congenital heart disease (with the exception of
bicuspid aortic valves), supravalvular or subvalvular
AS, or dynamic LVOT obstruction; 3) patients with
angina, syncope, and heart failure symptoms; and 4)
patients who denied authorization for research
participation. The present analysis included 488 pa-
tients with AS who were asymptomatic or minimally
symptomatic at the time of diagnosis. Symptoms were
ascertained by each patient’s personal cardiologist.
We considered as minimally symptomatic patients
presenting with atypical chest pain and elderly pa-
tients with minimal dyspnea not clearly related to AS.
A comorbidity index summating the patient’s in-
dividual comorbidities was calculated (20). Coronary
artery disease was deﬁned by the presence of docu-
mented history of acute coronary syndromes, coro-
nary artery disease previously conﬁrmed by coronary
angiography (reduction of the normal diameter $50%
in the left main coronary artery and $70% in the right
coronary, left anterior descending, and circumﬂex
arteries), or history of coronary revascularization.
We obtained Institutional Review Board authori-
zations before conducting the study. The study was
conducted in accordance with institutional policies,
ientnational legal requirements, and the revised Decla-
ration of Helsinki.
ECHOCARDIOGRAPHY. All patients underwent a
comprehensive Doppler-echocardiographic study
using commercially available ultrasound systems.
Peak aortic velocity was recorded using continuous-
wave Doppler in several acoustic windows (apical
5-chamber view, right parasternal, suprasternal,
epigastric). The highest aortic velocity was used to
calculate aortic time-velocity integral and MDG.
Pulsed Doppler LVOT velocity was recorded in the
apical 5-chamber view with the sample volume at
5 mm proximal from the plane of the aortic valve. The
alignment of both pulsed- and continuous-wave
Doppler was optimized to be parallel with the ﬂow.
Pressure gradients were calculated using the simpli-
ﬁed Bernoulli equation (21). AVA was calculated by
the continuity equation (4). The DI was computed
as ratio of the LVOT time-velocity integral to that
of the aortic valve jet (11). Stroke volume was calcu-
lated by multiplying the area of LVOT by the outﬂow
tract time-velocity integral and indexed to the body
surface area. When patients were in sinus rhythm,
3 cardiac cycles were averaged for all measures. For
patients in atrial ﬁbrillation, 5 cardiac cycles were
averaged.
Left ventricular dimensions were assessed from
parasternal long-axis views by 2-dimensional–guided
M-mode using the leading edge methodology at
end-diastole and -systole. EF was calculated using
Simpson’s biplane method. Left ventricular mass was
estimated by the formula on the basis of linear mea-
surements and indexed for body surface area (22).
The maximal velocity of the tricuspid regurgitation
was estimated using continuous-wave Doppler.
CLINICAL DECISION AND FOLLOW-UP. After the initial
medical management, treatment was conservative or
surgical, as deemed appropriate by the patient’s
personal physician. The majority of patients were
followed by clinical consultation and echocardiogra-
phy in the outpatient clinics of the 2 tertiary centers.
The others were followed in public hospitals or private
practices by referring cardiologists working together
with the tertiary centers. Information on follow-up
was retrospectively obtained. Events were ascer-
tained by direct patient interview and clinical exami-
nation and/or by repeated follow-up letters,
questionnaires, and telephone calls to physicians, pa-
tients, and (if necessary) next of kin. Autopsy records
and death certiﬁcates were consulted for attribution of
causes of death. Median follow-up was 32.0 months
(interquartile range: 8 to 58 months) and was 100%
complete. The main outcome variable was the time to
occurrence of the ﬁrst composite endpoint, deﬁned
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769as all-cause death or need for aortic valve replace-
ment. Secondary outcomes were all-cause death and
cardiac death. Clinical decisions regarding medical
management and referral for surgery were made by
the heart team with the approval of the patient’s
cardiologist in accordance with current practice
guidelines.
STATISTICAL ANALYSIS. Continuous variables were
expressed as mean  1 SD or median and interquartile
range, and categorical variables were summarized
as frequency percentages and counts. Receiver-
operating characteristic curves were used to establish
the best cutoff values for DI corresponding to
peak aortic jet velocities of 4 m/s and 5 m/s, ac-
cording to the best sensitivity, speciﬁcity, and likeli-
hood ratio. The study population was divided into
3 groups according to these determined cutoff
values: DI >0.25 (referent group), DI 0.20 to 0.25,
and DI <0.20. The relationship between the baseline
continuous baseline variables and the 3 groups was
explored using 1-way analysis of variance tests (for
normally distributed variables) or Kruskal-Wallis
tests (for non-normally distributed variables). Pear-
son’s chi-square statistic or Fisher exact test was used
to examine the association between the 3 groups and
the baseline categorical variables. The signiﬁcance
between the referent group and the others was
examined if there was a signiﬁcant difference across
categories. Individual differences were compared
with Mann Whitney U tests (with Bonferroni correc-
tion for multiple comparisons) and Tukey tests for
normally distributed data.
Event rates 1 SE of the 3 groups were estimated
according to the Kaplan-Meier method and compared
with 2-sided log-rank tests. Univariate and multivar-
iable analyses of time to events were performed using
Cox proportional hazards models with DI as the in-
dependent variable in continuous and categorical
format. We did not use model-building techniques
and entered in the models covariates considered of
potential prognostic impact on an epidemiological
basis. These covariates were age, sex, body surface
area, comorbidity index (not including age), history
of hypertension, coronary artery disease, EF, and
history of atrial ﬁbrillation. The model was further
adjusted for LVOT size in a second step. The propor-
tional hazards assumption was conﬁrmed using sta-
tistics and graphs on the basis of the Schoenfeld
residuals. For continuous variables, the assumption
of linearity was assessed by plotting residuals against
independent variables. We used penalized smoothing
splines (P-splines) to illustrate the association of DI as
a continuous variable and the risk of events (23). We
conducted subgroup analyses to determine thehomogeneity of the association of DI and the outcome
variable. First, we estimated the effect of DI on the
risk of events in each subgroup using a Cox univariate
model, and then we formally tested for ﬁrst-order
interactions in Cox models entering interaction
terms separately for each subgroup. We analyzed all-
cause death and cardiac death in Cox proportional
hazards multivariable models, while patients who
exhibited competing events during follow-up were
censored (as non-events) at the time of the event.
Hazard ratios (HRs) and 95% conﬁdence intervals
(CIs) were estimated for all-cause death and for car-
diac death. Plots of cumulative hazard functions were
used to graphically display death due to cardiac cau-
ses. Finally, to investigate whether DI has incremen-
tal value for risk prediction over classic markers of AS
severity (peak aortic jet velocity and AVA), we used
the Harrell C statistic in adjusted Cox proportional
hazard models. In addition, 95% CIs of these C sta-
tistics were calculated by the “somersd” package in
STATA version 12 (StataCorp LP, College Station,
Texas) (24). All p values are the results of 2-tailed
tests. Data were analyzed with SPSS version 13.0
(SPSS Inc., Chicago, Illinois) and STATA version 12
(StataCorp LP).
RESULTS
BASELINE CHARACTERISTICS. The study population
consisted of 488 patients with AS who were enrolled
at 2 tertiary hospitals in France (350 patients at
Amiens and 138 patients at Lille) between 2000 and
2012. The median age of the population was 75.8
years (interquartile range: 66.9 to 81.9 years), and
more than 50% were male (Table 1). All patients were
asymptomatic or had minimal subjective symptoms
at the time of diagnosis. Seventy percent of patients
had a history of hypertension, and coronary artery
disease was present in approximately one-third of
patients (Table 1).
According to receiver-operating characteristic
curve analysis, the best DI cutoff for the prediction of
peak aortic jet velocity >4 m/s was 0.25 (sensitivity
85%, speciﬁcity 82%). The corresponding value for
peak aortic jet velocity >5 m/s was 0.20 (sensitivity
82%, speciﬁcity 87%). On the basis of these cutoffs,
the study population was divided into 3 groups:
1) DI <0.20; 2) DI 0.20 to 0.25; and 3) DI >0.25.
The study groups showed no difference in age,
sex, body surface area, and frequency of coronary
artery disease. Patients with DI <0.20 frequently
had hypertension and a lower comorbidity index
(Table 1). As expected, lower DI was associated with
smaller AVA and higher MDG (Table 2). Although
TABLE 1 Baseline Demographic and Clinical Characteristics of the Study Patients According to DI
All Patients
(n ¼ 488)
Group
p Value
DI <0.20
(n ¼ 86, 18%)
DI 0.20–0.25
(n ¼ 117, 24%)
DI >0.25
(n ¼ 285, 58%)
Demographics, baseline data, and symptoms
Age, yrs 75.8 (66.9–81.9) 74.4 (63.9–82.1) 75.3 (66.5–81.3) 76.1 (67.3–82.2) 0.46
Male 56.8 (277) 61.6 (53) 57.3 (67) 55.1 (157) 0.56
Body surface area, m2 1.9  0.2 1.8  0.2 1.9  0.2 1.9  0.2 0.19
Body mass index, kg/m2 27.1 (24.2–30.1) 26.5 (23.4–29.8) 27.8 (24.6–31.2) 27.1 (24.3–30.1) 0.27
Systolic blood pressure, mm Hg 140 (125–150) 140 (120–144) 140 (122–150) 140 (128–150) 0.35
Medical history and risk factors
Hypertension 70.3 (343) 57.0 (49)* 70.9 (83) 74.0 (211) 0.01
Smoking 28.3 (138) 27.9 (24) 31.6 (37) 27.0 (77) 0.65
Dyslipidemia 40.0 (195) 38.4 (33) 41.9 (49) 39.6 (113) 0.87
Diabetes mellitus 30.5 (149) 24.4 (21) 30.8 (36) 32.3 (92) 0.38
Coronary artery disease 24.8 (121) 27.9 (24) 26.5 (31) 23.2 (66) 0.60
History of atrial ﬁbrillation 29.1 (142) 22.1 (19) 30.8 (36) 30.5 (87) 0.29
Charlson Comorbidity Index 2 (1–3) 1 (1–2)* 2 (1–3) 2 (1–3) 0.001
Values are mean  1 SD, median (interquartile range), or % (n). *p < 0.05 individual category versus DI >0.25.
DI ¼ dimensionless index.
TABLE 2 Echocardiographic Parameters of the 3 Groups of Patients With AS According to DI
All Patients
(n ¼ 488)
Group
p Value
DI <0.20
(n ¼ 86, 18%)
DI 0.20–0.25
(n ¼ 117, 24%)
DI >0.25
(n ¼ 285, 58%)
Aortic valve
AVA, cm2 1.02 (0.8–1.38) 0.66 (0.59–0.79)* 0.86 (0.75–0.99)* 1.3 (1.1–1.5) <0.001
Indexed AVA, cm2/m2 0.55 (0.42–0.70) 0.36 (0.30–0.41)* 0.45 (0.39–0.51)* 0.67 (0.58–0.78) <0.001
Peak aortic jet velocity, m/s 3.3 (2.7–4.1) 4.5 (4.1–5.0)* 3.9 (3.4–4.4)* 2.9 (2.5–3.3) <0.001
Transaortic mean pressure gradient, mm Hg 28 (18–41) 51 (42–65)* 37 (30–50)* 20 (15–27) <0.001
Aortic valve velocity time integral, cm 76 (60–99) 110 (95–130)* 94 (79–109)* 63 (53–75) <0.001
Valvulo-arterial impedance, mm Hg/ml/m2 4.2  1.3 5.0  1.6* 4.4  1.2* 3.9  1.1 <0.001
Cardiac output
LVOT diameter, mm 22 (20–23) 22.2 (21–24) 22 (21–23) 21 (20–23) 0.10
LVOT velocity time integral, cm 21 (18–24) 18 (15–21)* 21 (18–25)† 22 (19–24) <0.001
Stroke volume, ml 79 (65–91) 73 (67–95)† 79 (67–95) 80 (66–94) 0.016
Indexed stroke volume, ml/m2 41 (34–48) 39 (33–45) 41 (35–49) 42 (35–48) 0.10
Indexed stroke volume <35 ml/m2 25.8 (126) 30.2 (26) 24.8 (29) 24.8 (71) 0.58
Cardiac output, ml/min 5.7 (4.7–6.8) 5.3 (4.4–6.4)† 5.9 (4.9–6.9) 5.8 (4.8–6.9) 0.036
LV function
LV end-diastolic diameter, mm 49 (45–53) 49 (44–52) 50 (46–54) 49 (44–53) 0.52
LV end-systolic diameter, mm 30 (27–34) 32 (28–36) 31 (27–34) 30 (26–33) 0.13
LV end-diastolic septum thickness, mm 12 (11–14) 13 (11–14) 13 (11–14) 12 (10–14) 0.12
LV end-diastolic posterior wall thickness, mm 11 (9–12) 11 (9–13) 11 (10–13) 11 (9–12) 0.16
EF, % 65 (59–72) 63 (56–70) 65 (60–70) 65 (58–69) 0.54
LV mass, g 213 (170–264) 220 (171–279) 218 (166–261) 207 (166–249) 0.10
Indexed LV mass, g/m2 110 (91–137) 119 (94–148)† 111 (88–137) 107 (89–129) 0.024
Other parameters
Left atrial diameter, mm 40.6  7.4 41.5  7.8 40.5  6.9 39.9  7.5 0.47
Left atrial surface, cm2 23.1  6.4 23.7  6.3 23.5  7.2 22.7  5.9 0.63
Systolic pulmonary artery pressure, mm Hg 30.5 (26–38) 32 (26–40) 31 (26–39) 30 (26–36) 0.25
Values are mean 1 SD, median (interquartile range), or % (n). *p < 0.001 individual category versus DI >0.25. †p < 0.05 individual category versus DI >0.25.
AVA ¼ aortic valve area; EF ¼ ejection fraction; LV ¼ left ventricular; LVOT ¼ left ventricular outﬂow tract; other abbreviation as in Table 1.
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FIGURE 1 Kaplan-Meier Event-Free Survival Curves According to DI Categories
Patients at Risk
Overall log-rank p value < 0.001
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DI < 0.20
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DI ¼ dimensionless index.
TABLE 3 Relative Risk of Events (All-Cause Death or Aortic
Valve Replacement Surgery) During Follow-Up Associated With DI
HR (95% CI) p Value
DI categories
Unadjusted
DI > 0.25 Referent
DI 0.20–0.25 1.45 (1.06–1.98) 0.021
DI < 0.20 2.33 (1.71–3.18) <0.001
Model 1*
DI > 0.25 Referent
DI 0.20–0.25 1.61 (1.19–2.21) 0.004
DI < 0.20 2.50 (1.84–3.45) <0.001
Model 2†
DI > 0.25 Referent
DI 0.20–0.25 1.65 (1.20–2.27) 0.002
DI < 0.20 2.62 (1.90–3.63) <0.001
Per 0.05 decrement in DI
Unadjusted 1.22 (1.14–1.31) <0.001
Model 1* 1.23 (1.14–1.33) <0.001
Model 2† 1.24 (1.16–1.39) <0.001
*Adjustment for age, sex, Charlson comorbidity index, history of hypertension,
coronary artery disease, history of atrial ﬁbrillation, body surface area and left
ventricular ejection fraction. †Adjustment for age, sex, Charlson comorbidity index,
history of hypertension, coronary artery disease, history of atrial ﬁbrillation, body
surface area, left ventricular ejection fraction, and left ventricular outﬂow tract
diameter. Charlson comorbidity index does not include age.
CI ¼ conﬁdence interval; DI ¼ dimensionless index; HR ¼ hazard ratio.
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771LVOT size was not signiﬁcantly different across the
3 DI groups, smaller LVOT time-velocity integral and
lower stroke volume were associated with lower DI.
Indexed left ventricular mass was greater in patients
with DI <0.20 (Table 2).
PROGNOSTIC IMPLICATION OF DI. During follow-
up, 241 events (117 deaths, including 54 deaths of
cardiac causes, and 124 aortic valve replacements)
were recorded. In patients who underwent surgery,
aortic bioprostheses were used in 80% of cases
(n ¼ 99) and 45 patients had at least 1 associated
coronary artery bypass graft at the time of surgery.
Overall, 1-, 3-, and 5-year survival free of events was
78  2%, 60  2%, and 46  3%, respectively. The
5-year event-free survival was 56  3% for DI >0.25,
41  6% for DI 0.20 to 0.25, and 22  5% for DI <0.20
(p for trend <0.001) (Figure 1). On univariate Cox
analysis, the risk of events increased with lower DI
(HR: 1.22; 95% CI: 1.14 to 1.31 per 0.05 DI decrement)
(Table 3). The relationship remained unchanged after
adjustment for covariates of prognostic importance
(adjusted HR: 1.24; 95% CI: 1.16 to 1.39 per 0.05 DI
decrement) (Table 3). The character of the relation-
ship between the DI as continuous variable and
the risk of events during follow-up was estimated
using spline functions for DI (Figure 2). On multivar-
iable analysis, there was no increase in the risk of
events with decreasing DI when it remained >0.25
(adjusted HR: 1.09; 95% CI: 0.89 to 1.24 per 0.05 DI
decrement). With DI #0.25, there was a signiﬁcant
increase in the risk of events with decreasing DI
(adjusted HR: 1.14; 95% CI: 1.05 to 1.29 per 0.05 DI
decrement). Compared with patients with DI >0.25,
those with DI 0.20 to 0.25 and those with DI <0.20
displayed an excess risk of events (HR: 1.45; 95% CI:
1.06 to 1.98; p ¼ 0.021 for DI 0.20 to 0.25 vs. DI >0.25,
and HR: 2.33; 95% CI: 1.71 to 3.18; p < 0.001 for
DI <0.20 vs. DI >0.25) (Table 3). The relationships
were strengthened after adjustment for covariates
(adjusted HR: 1.65; 95% CI: 1.20 to 2.27; p ¼ 0.002
for DI 0.20 to 0.25 vs. DI >0.25, and adjusted
HR: 2.62; 95% CI: 1.90 to 3.63; p < 0.001 for DI <0.20
vs. DI >0.25) (Table 3, Figure 3). The full results
of the multivariable models for the prediction of
events during follow-up are presented in Online
Table 1. In multivariable analyses, the addition
of DI to the model with AVA and peak aortic jet
velocity resulted in an incremental improvement in
the overall performance of the model (Harrell C
statistic: 0.714 vs. 0.674; p ¼ 0.004 for AVA plus
peak aortic jet velocity plus DI vs. AVA plus peak
aortic jet velocity and 0.714 vs. 0.667; p ¼ 0.002 for
AVA plus peak aortic jet velocity plus DI vs. AVA
alone) (Online Table 2). The association of DI #0.25and risk of events was consistent in subgroups of
patients with AS (Figure 4). There were no signiﬁcant
interactions between DI #0.25 and any of the
subgroups.
FIGURE 2 Relationship Between DI and Risk of Events During Follow-Up
Lo
g 
Ha
za
rd
DI
0.1 0.15 0.2 0.25 0.3 0.35 0.4
-1
0
1
Hazard ratio (solid line) and 95% conﬁdence intervals (dashed lines) are estimated in a
Cox model with DI represented as a spline function and adjusted for age, sex, comorbidity
index, coronary artery disease, hypertension, atrial ﬁbrillation, ejection fraction, body
surface area, and left ventricular outﬂow tract. DI ¼ dimensionless index.
FIGURE 3 Adjusted Curves of Event-Free Survival According to DI Categories
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Curves are adjusted for age, sex, comorbidity index, coronary artery disease, hypertension,
atrial ﬁbrillation, ejection fraction, body surface area, and left ventricular outﬂow
tract size. DI ¼ dimensionless index.
Rusinaru et al. J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 8 , N O . 7 , 2 0 1 5
Dimensionless Index in Aortic Stenosis J U L Y 2 0 1 5 : 7 6 6 – 7 5
772On multivariable analysis, DI #0.25 was not asso-
ciated with a signiﬁcantly greater risk of all-cause
death during follow-up (adjusted HR: 1.23; 95% CI:
0.78 to 1.96; p ¼ 0.37). However, with DI #0.25, there
was a signiﬁcant increase in the risk of cardiac death
compared with DI >0.25 (adjusted HR: 2.08; 95% CI:
1.06 to 4.11; p ¼ 0.034) (Figure 5).
DISCUSSION
To the best of our knowledge, this is the ﬁrst study to
speciﬁcally assess the outcome implication of DI in a
large population of patients with AS and preserved EF
irrespective of mean pressure gradient. According to
our results, DI independently predicts the occurrence
of events (death or aortic valve replacement) and
cardiac death after AS diagnosis. The prognostic
impact of DI was powerful, because after adjustment
for age, sex, comorbidity, coronary artery disease, EF,
LVOT size, and other variables of prognostic impor-
tance, each 0.05 DI decrement was associated with an
approximately 25% increase in the risk of all-cause
death or need for aortic surgery. Moreover, we
observed an abrupt increase in the risk of events
below the 0.25 cutoff, suggesting that from a prog-
nostic point of view, DI #0.25 truly deﬁnes severe AS.
Finally, the DI performs well in subgroups of patients
with AS, with no interaction between its prognostic
power and sex, body surface area, LVOT size, or
stroke volume.
Peak aortic jet velocity and MDG are the corner-
stones of AS severity assessment (1,2). In patients with
normal transvalvular ﬂow and calciﬁed aortic valves,
the sole detection of a peak aortic jet velocity $4 m/s
establishes the diagnosis of severe AS. In the last
American Heart Association/American College of
Cardiology guidelines on valvular heart disease, AVA
appears as a second-line parameter, of special interest
in cases with low transvalvular ﬂow (2). Both param-
eters have limitations and should be viewed as com-
plementary in a multiparametric strategy of AS
severity assessment (25). Peak aortic jet velocity and
MDG are inﬂuenced by volume ﬂow rate. Moreover,
accurate recording of peak aortic jet velocity requires
parallel alignment between the continuous Doppler
ultrasound beam and the aortic ﬂow, nonparallel
intercept angle leading to underestimation of AS
severity. In regard to the calculation of the AVA by the
continuity equation, it is subject to errors because of
the notoriously difﬁcult measure of the LVOT cross-
sectional area. First, from a theoretical standpoint,
the assumption that the cross-sectional area is circular
has not been conﬁrmed by recent echocardiography
and computed tomography studies (6,7,26). On the
FIGURE 4 HR and 95% CI for Risk of Events Associated With DI #0.25 in Subgroups of Patients With AS
Subgroup
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AS ¼ aortic stenosis; CI ¼ conﬁdence interval; DI ¼ dimensionless index; HR ¼ hazard ratio; LV ¼ left ventricular; SV ¼ stroke volume.
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773other hand, from a practical point of view, an accurate
measure of the LVOT size by 2-dimensional echocar-
diography is elusive in patients with massive calciﬁ-
cation of the aortic annulus or in case of a poor acoustic
window. Finally, the best site for LVOT size measure-
ment is still debated (3,8,9). Although guidelines
recommend a mid-systole measurement from the
septal endocardium to the anterior mitral leaﬂet par-
allel to the aortic plane, 5 to 10 mm below the valve
oriﬁce (3), current practice generally uses simpler, yet
reliable measures of LVOT diameter at the level of
aortic cusp insertion (9,12).
DI represents the ratio of the LVOT time-velocity
integral to that of the aortic valve jet (11,12). In a
study of 48 patients with AS undergoing cardiac
catheterization, Otto et al. (11) reported that DI
showed better sensitivity than Doppler pressure
gradient to identify severe AS (97% vs. 81%). Subse-
quently, Oh et al. (12) reported a similar correlation
between anatomic AVA and Doppler-derived AVA
calculated with time-velocity integral ratio or peakvelocity ratio and proposed 0.25 as the velocity ratio
cutoff to identify severe AS. This index has the po-
tential advantage to be independent of a patient’s
body surface area (3) and is not inﬂuenced by the
estimation of the LVOT cross-sectional area. Current
guidelines recommend the 0.25 DI cutoff to deﬁne
severe AS (1,3).
Several studies have validated the outcome impli-
cations of the different Doppler-derived parameters
for AS severity assessment. The prognostic impact of
peak aortic jet velocity in AS has been well demon-
strated (13–16). Otto et al. (13) reported an inverse
relationship between peak aortic jet velocity and
outcome in asymptomatic AS. In asymptomatic pa-
tients with very severe AS, Rosenhek et al. (16)
observed that higher peak aortic jet velocity is related
to a pejorative outcome. MDG has rarely been vali-
dated as a predictor of outcome in severe AS, but it
shows a close linear correlation with peak aortic jet
velocity (10,17), reﬂecting the same phenomenon. The
impact of AVA on outcome is somewhat less clearly
FIGURE 5 Cumulative Hazard of Cardiac Death According to DI Categories
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Curves are adjusted for age, sex, comorbidity index, coronary artery disease, hypertension,
atrial ﬁbrillation, EF, body surface area, and LVOT size. Abbreviations as in Figures 1 and 2.
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774established. Although some studies reported that
AVA <1 cm2 and indexed AVA <0.6 cm2/m2 strongly
affect outcome, irrespective of peak aortic jet velocity
and MDG (18), others fail to identify a link between
AVA and outcome (16,19). We demonstrate the link
between the 0.25 DI cutoff previously proposed and
recommended by guidelines and the occurrence of
events in a large population of patients with AS. We
also show that patients with AS with DI <0.20 corre-
spond in terms of outcome to very severe AS, as
deﬁned by Rosenhek et al. (16). Furthermore, we
show that the prediction of events in patients with AS
and preserved EF is best achieved by a combination of
severity markers, such as AVA, peak aortic jet veloc-
ity, and DI, which strongly suggests the value of a
multiparametric approach, especially in difﬁcult
cases. Although previous studies have suggested that
the DI cutoff for severe AS is variable according to
LVOT diameter (27), our analysis shows that the
prognostic implication of DI is not affected by LVOT
diameter, body surface area, and stroke volume.
Thus, DI might be particularly useful in patients in
whom the estimation of the LVOT cross-sectional area
is difﬁcult. Our ﬁndings are in accordance with a
recent subanalysis of the SEAS (Simvastatin and
Ezetimibe in Aortic Stenosis) trial showing that DI is
strongly associated with valve-related events inasymptomatic patients with severe low-gradient AS
and preserved EF (28). This index remains to be
tested in patients with low-ﬂow, low-gradient AS and
preserved EF, in whom the rate of measurement in-
consistencies is considerable.
STUDY LIMITATIONS. Information on follow-up was
retrospectively obtained, and therefore, our study
has the inherent limitations of such analyses. The
speciﬁc indications for surgery during follow-up were
not collected in our database. However, diagnosis and
follow-up were performed by cardiologists with
expertise in valvular disease, and the surgical de-
cisions were made by the heart team with the
approval of the patients’ physicians in accordance
with current practice guidelines. For this analysis, we
included patients with AS and no symptoms or min-
imal subjective manifestations. Indeed, we consider
that among elderly patients with AS, it is often difﬁ-
cult to differentiate asymptomatic individuals from
patients who have minimal subjective manifesta-
tions. Patients were enrolled at the time of baseline
echocardiography, and medical treatment at baseline
was not systematically recorded. We acknowledge
that medical therapy might affect outcomes in this
cohort of patients with AS with various degrees of
severity. Finally, we would like to point out that we
studied exclusively asymptomatic and minimally
symptomatic patients with AS with preserved EF and
without signiﬁcant valve regurgitation. Further
studies are needed to evaluate the role of DI in other
subsets of patients with AS.
CONCLUSIONS
This analysis of a large registry of valvular AS in
routine clinical practice shows that the DI is a valu-
able parameter in deﬁning the severity of AS and in
predicting the occurrence of events after diagnosis.
The risk of events increases linearly with DI
decreasing below the 0.25 cutoff and is considerable
in patients with DI <0.20. Therefore, DI seems useful
to identify severe AS with poor prognosis and might
help to reconcile discordant results between valve
area and pressure gradient. These ﬁndings support
the widespread use of this simple and reliable
parameter for AS severity assessment and for thera-
peutic decisions.
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PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: The DI
represents an easily obtainable prognostic marker for
characterizing the severity of AS. The risk of cardiac
events after AS diagnosis increases linearly with DI <0.25
cutoff and is considerable with DI <0.20.
COMPETENCY IN PATIENT CARE AND PROCE-
DURAL SKILLS: The DI should be measured in all pa-
tients with AS and used as a severity marker and for
outcome prediction. Because assessment of DI does not
require the measurement of LVOT cross-sectional area,
errors related to the measurement of the LVOT area can
be easily circumvented.
TRANSLATIONAL OUTLOOK: The prognostic value of
DI does not seem to be inﬂuenced by sex, body surface
area, LVOT size, or stroke volume. Prospective studies are
needed to test the value of the DI in patients with low-
ﬂow, low-gradient AS and preserved EF, in whom mea-
surement errors may be frequently encountered.
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